D
Vivos Inc.
RDGL
$0.1178
$0.00131.12%
D
Sell
3/10/2025Upgraded
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/10/2025 due to an increase in the volatility index, total return index and valuation index.
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/10/2025 due to an increase in the volatility index, total return index and valuation index.
E
Sell
2/21/2025Downgrade
Vivos Inc. (RDGL) was downgraded to E+ from D- on 2/21/2025 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0012 to -$0.002, total revenue declined 62.96% from $13.5 to $5, and EBIT declined 61.42% from -$522.3 to -$843.1.
Vivos Inc. (RDGL) was downgraded to E+ from D- on 2/21/2025 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0012 to -$0.002, total revenue declined 62.96% from $13.5 to $5, and EBIT declined 61.42% from -$522.3 to -$843.1.
D
Sell
3/11/2024Upgraded
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/11/2024 due to a large increase in the growth index, solvency index and volatility index. Operating cash flow increased 111.79% from -$608 to $71.7, earnings per share increased from -$0.0025 to -$0.0018, and EBIT increased 24.8% from -$914.4 to -$687.6.
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/11/2024 due to a large increase in the growth index, solvency index and volatility index. Operating cash flow increased 111.79% from -$608 to $71.7, earnings per share increased from -$0.0025 to -$0.0018, and EBIT increased 24.8% from -$914.4 to -$687.6.
E
Sell
11/3/2023Downgrade
Vivos Inc. (RDGL) was downgraded to E+ from D- on 11/3/2023 due to a noticeable decline in the volatility index and growth index. EBIT declined 268.26% from -$248.3 to -$914.4, earnings per share declined from -$0.0007 to -$0.0025, and operating cash flow declined 107.08% from -$293.6 to -$608.
Vivos Inc. (RDGL) was downgraded to E+ from D- on 11/3/2023 due to a noticeable decline in the volatility index and growth index. EBIT declined 268.26% from -$248.3 to -$914.4, earnings per share declined from -$0.0007 to -$0.0025, and operating cash flow declined 107.08% from -$293.6 to -$608.
D
Sell
3/14/2023Downgrade
Vivos Inc. (RDGL) was downgraded to D- from D on 3/14/2023 due to a substantial decline in the growth index. EBIT declined 154.67% from -$277.1 to -$705.7, and earnings per share declined from -$0.0008 to -$0.002.
Vivos Inc. (RDGL) was downgraded to D- from D on 3/14/2023 due to a substantial decline in the growth index. EBIT declined 154.67% from -$277.1 to -$705.7, and earnings per share declined from -$0.0008 to -$0.002.
D
Sell
2/23/2023Upgraded
Vivos Inc. (RDGL) was upgraded to D from D- on 02/23/2023.
Vivos Inc. (RDGL) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Vivos Inc. (RDGL) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
Vivos Inc. (RDGL) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
1/4/2023Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 1/4/2023 due to a decline in the total return index and volatility index.
Vivos Inc. (RDGL) was downgraded to D from D+ on 1/4/2023 due to a decline in the total return index and volatility index.
D
Sell
12/20/2022Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D on 12/20/2022 due to an increase in the valuation index.
Vivos Inc. (RDGL) was upgraded to D+ from D on 12/20/2022 due to an increase in the valuation index.
D
Sell
10/20/2022Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 10/20/2022 due to a decline in the growth index, total return index and valuation index. Operating cash flow declined 65.4% from -$171.1 to -$283, and total revenue declined 38.1% from $10.5 to $6.5.
Vivos Inc. (RDGL) was downgraded to D from D+ on 10/20/2022 due to a decline in the growth index, total return index and valuation index. Operating cash flow declined 65.4% from -$171.1 to -$283, and total revenue declined 38.1% from $10.5 to $6.5.
D
Sell
9/30/2022Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D on 9/30/2022 due to an increase in the volatility index.
Vivos Inc. (RDGL) was upgraded to D+ from D on 9/30/2022 due to an increase in the volatility index.
D
Sell
9/14/2022Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 9/14/2022 due to a decline in the total return index and volatility index.
Vivos Inc. (RDGL) was downgraded to D from D+ on 9/14/2022 due to a decline in the total return index and volatility index.
D
Sell
7/26/2022Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D on 7/26/2022 due to a major increase in the growth index. Operating cash flow increased 55.48% from -$384.3 to -$171.1.
Vivos Inc. (RDGL) was upgraded to D+ from D on 7/26/2022 due to a major increase in the growth index. Operating cash flow increased 55.48% from -$384.3 to -$171.1.
D
Sell
5/5/2022Upgraded
Vivos Inc. (RDGL) was upgraded to D from D- on 05/05/2022.
Vivos Inc. (RDGL) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Vivos Inc. (RDGL) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
Vivos Inc. (RDGL) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
D
Sell
11/23/2021Upgraded
Vivos Inc. (RDGL) was upgraded to D from D- on 11/23/2021.
Vivos Inc. (RDGL) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Vivos Inc. (RDGL) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the total return index.
Vivos Inc. (RDGL) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the total return index.
D
Sell
11/3/2021Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 11/3/2021 due to a decline in the total return index and valuation index.
Vivos Inc. (RDGL) was downgraded to D from D+ on 11/3/2021 due to a decline in the total return index and valuation index.
D
Sell
10/22/2021Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D on 10/22/2021 due to a significant increase in the total return index, solvency index and volatility index.
Vivos Inc. (RDGL) was upgraded to D+ from D on 10/22/2021 due to a significant increase in the total return index, solvency index and volatility index.
D
Sell
11/30/2020Upgraded
Vivos Inc. (RDGL) was upgraded to D from D- on 11/30/2020 due to an increase in the volatility index, valuation index and total return index.
Vivos Inc. (RDGL) was upgraded to D from D- on 11/30/2020 due to an increase in the volatility index, valuation index and total return index.
D
Sell
11/9/2020Downgrade
Vivos Inc. (RDGL) was downgraded to D- from D on 11/9/2020 due to a major decline in the growth index, valuation index and total return index.
Vivos Inc. (RDGL) was downgraded to D- from D on 11/9/2020 due to a major decline in the growth index, valuation index and total return index.
D
Sell
5/15/2020Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 5/15/2020 due to a significant decline in the efficiency index and total return index.
Vivos Inc. (RDGL) was downgraded to D from D+ on 5/15/2020 due to a significant decline in the efficiency index and total return index.
D
Sell
4/30/2020Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D- on 4/30/2020 due to a significant increase in the efficiency index and growth index. EBIT increased 46.54% from -$607.2 to -$324.6, earnings per share increased from -$0.0038 to -$0.0027, and net income increased 24.71% from -$669.4 to -$504.
Vivos Inc. (RDGL) was upgraded to D+ from D- on 4/30/2020 due to a significant increase in the efficiency index and growth index. EBIT increased 46.54% from -$607.2 to -$324.6, earnings per share increased from -$0.0038 to -$0.0027, and net income increased 24.71% from -$669.4 to -$504.
D
Sell
4/22/2020Upgraded
Vivos Inc. (RDGL) was upgraded to D- from E+ on 4/22/2020 due to an increase in the total return index and volatility index.
Vivos Inc. (RDGL) was upgraded to D- from E+ on 4/22/2020 due to an increase in the total return index and volatility index.
E
Sell
4/7/2020Downgrade
Vivos Inc. (RDGL) was downgraded to E+ from D- on 4/7/2020 due to a decline in the volatility index.
Vivos Inc. (RDGL) was downgraded to E+ from D- on 4/7/2020 due to a decline in the volatility index.
D
Sell
3/23/2020Upgraded
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/23/2020 due to an increase in the volatility index and total return index.
Vivos Inc. (RDGL) was upgraded to D- from E+ on 3/23/2020 due to an increase in the volatility index and total return index.
E
Sell
3/4/2020Downgrade
Vivos Inc. (RDGL) was downgraded to E+ from D- on 3/4/2020 due to a decline in the total return index and volatility index.
Vivos Inc. (RDGL) was downgraded to E+ from D- on 3/4/2020 due to a decline in the total return index and volatility index.
D
Sell
11/29/2019Upgraded
Vivos Inc. (RDGL) was upgraded to D- from E+ on 11/29/2019 due to an increase in the total return index and volatility index.
Vivos Inc. (RDGL) was upgraded to D- from E+ on 11/29/2019 due to an increase in the total return index and volatility index.
E
Sell
11/13/2019Downgrade
Vivos Inc. (RDGL) was downgraded to E+ from D on 11/13/2019 due to a significant decline in the efficiency index, growth index and total return index. EBIT declined 250.98% from -$173 to -$607.2, net income declined 234.2% from -$200.3 to -$669.4, and earnings per share declined from -$0.0012 to -$0.0038.
Vivos Inc. (RDGL) was downgraded to E+ from D on 11/13/2019 due to a significant decline in the efficiency index, growth index and total return index. EBIT declined 250.98% from -$173 to -$607.2, net income declined 234.2% from -$200.3 to -$669.4, and earnings per share declined from -$0.0012 to -$0.0038.
D
Sell
10/11/2019Downgrade
Vivos Inc. (RDGL) was downgraded to D from D+ on 10/11/2019 due to a large decline in the total return index.
Vivos Inc. (RDGL) was downgraded to D from D+ on 10/11/2019 due to a large decline in the total return index.
D
Sell
9/26/2019Upgraded
Vivos Inc. (RDGL) was upgraded to D+ from D on 9/26/2019 due to a large increase in the total return index, growth index and efficiency index. Operating cash flow increased 53.15% from -$271.7 to -$127.3, EBIT increased 23.18% from -$225.2 to -$173, and net income increased 15.27% from -$236.4 to -$200.3.
Vivos Inc. (RDGL) was upgraded to D+ from D on 9/26/2019 due to a large increase in the total return index, growth index and efficiency index. Operating cash flow increased 53.15% from -$271.7 to -$127.3, EBIT increased 23.18% from -$225.2 to -$173, and net income increased 15.27% from -$236.4 to -$200.3.
D
Sell
10/2/2017Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from D+ on 10/2/2017 due to a decline in the volatility index, total return index and valuation index.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from D+ on 10/2/2017 due to a decline in the volatility index, total return index and valuation index.
D
Sell
5/17/2017Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to D+ from D on 5/17/2017 due to a large increase in the efficiency index, volatility index and growth index. EBIT increased 22.81% from -$472.5 to -$364.7, total capital increased 18.5% from -$2.14M to -$1.75M, and operating cash flow increased 1.85% from -$280.9 to -$275.7.
Advanced Medical Isotope Corporation (ADMD) was upgraded to D+ from D on 5/17/2017 due to a large increase in the efficiency index, volatility index and growth index. EBIT increased 22.81% from -$472.5 to -$364.7, total capital increased 18.5% from -$2.14M to -$1.75M, and operating cash flow increased 1.85% from -$280.9 to -$275.7.
D
Sell
3/10/2017Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from C- on 3/10/2017 due to a major decline in the efficiency index and growth index. Operating cash flow declined 75.34% from -$160.2 to -$280.9.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from C- on 3/10/2017 due to a major decline in the efficiency index and growth index. Operating cash flow declined 75.34% from -$160.2 to -$280.9.
C
Hold
2/28/2017Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 2/28/2017 due to an increase in the total return index and volatility index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 2/28/2017 due to an increase in the total return index and volatility index.
D
Sell
2/13/2017Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 2/13/2017 due to a decline in the volatility index.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 2/13/2017 due to a decline in the volatility index.
C
Hold
12/22/2016Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 12/22/2016 due to an increase in the total return index and volatility index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 12/22/2016 due to an increase in the total return index and volatility index.
D
Sell
11/22/2016Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 11/22/2016 due to a noticeable decline in the total return index, growth index and volatility index.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 11/22/2016 due to a noticeable decline in the total return index, growth index and volatility index.
C
Hold
10/10/2016Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 10/10/2016 due to a large increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.0029 to -$0.0021.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 10/10/2016 due to a large increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.0029 to -$0.0021.
D
Sell
6/27/2016Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 6/27/2016 due to a decline in the volatility index and total return index.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 6/27/2016 due to a decline in the volatility index and total return index.
C
Hold
6/10/2016Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D on 6/10/2016 due to a significant increase in the efficiency index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D on 6/10/2016 due to a significant increase in the efficiency index.
D
Sell
5/26/2016Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from C- on 5/26/2016 due to a significant decline in the efficiency index and growth index. EBIT declined 452.72% from -$293.8 to -$1.62M, operating cash flow declined 291.73% from -$131.8 to -$516.3, and total revenue declined 100% from $12.1 to $0.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D from C- on 5/26/2016 due to a significant decline in the efficiency index and growth index. EBIT declined 452.72% from -$293.8 to -$1.62M, operating cash flow declined 291.73% from -$131.8 to -$516.3, and total revenue declined 100% from $12.1 to $0.
C
Hold
5/16/2016Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 5/16/2016 due to a substantial increase in the valuation index and volatility index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 5/16/2016 due to a substantial increase in the valuation index and volatility index.
D
Sell
4/12/2016Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 4/12/2016 due to a substantial decline in the valuation index.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C- on 4/12/2016 due to a substantial decline in the valuation index.
C
Hold
3/28/2016Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 3/28/2016 due to an increase in the volatility index and total return index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C- from D+ on 3/28/2016 due to an increase in the volatility index and total return index.
D
Sell
3/11/2016Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and efficiency index. Net income declined 138.52% from $6.57M to -$2.53M.
Advanced Medical Isotope Corporation (ADMD) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and efficiency index. Net income declined 138.52% from $6.57M to -$2.53M.
C
Hold
5/26/2015Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C from C- on 5/26/2015 due to a substantial increase in the valuation index and growth index.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C from C- on 5/26/2015 due to a substantial increase in the valuation index and growth index.
C
Hold
5/14/2015Downgrade
Advanced Medical Isotope Corporation (ADMD) was downgraded to C- from C on 5/14/2015 due to a major decline in the growth index and total return index. EBIT declined 22.18% from -$493.3 to -$383.9.
Advanced Medical Isotope Corporation (ADMD) was downgraded to C- from C on 5/14/2015 due to a major decline in the growth index and total return index. EBIT declined 22.18% from -$493.3 to -$383.9.
C
Hold
8/15/2014Upgraded
Advanced Medical Isotope Corporation (ADMD) was upgraded to C from C- on 8/15/2014 due to a major increase in the growth index, valuation index and efficiency index. Total capital increased 14.48% from -$4.07M to -$4.66M, and net income increased 14.09% from -$1.08M to -$1.24M.
Advanced Medical Isotope Corporation (ADMD) was upgraded to C from C- on 8/15/2014 due to a major increase in the growth index, valuation index and efficiency index. Total capital increased 14.48% from -$4.07M to -$4.66M, and net income increased 14.09% from -$1.08M to -$1.24M.
OTC PK
03/12/2025 3:33PM Eastern
Quotes delayed
